Hsbc Holdings PLC Royalty Pharma PLC Transaction History

Hsbc Holdings PLC

$176 Billion
Q3 2025

A detailed history of Hsbc Holdings PLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Hsbc Holdings PLC holds 239,708 shares of RPRX stock, worth $9.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

239,708

Previous 36,300 560.35%

Holding current value

$9.39 Million

Previous $1.31 Million 546.98%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$34.9 - $37.91 $7.1 Million - $7.71 Million	203,408 Added 560.35%	239,708 $8.46 Million
Q2 2025 Aug 13, 2025	SELL	$30.85 - $36.14 $2.39 Million - $2.8 Million	-77,498 Reduced 68.1%	36,300 $1.31 Million
Q1 2025 May 14, 2025	SELL	$25.75 - $33.86 $1.51 Million - $1.98 Million	-58,518 Reduced 33.96%	113,798 $3.54 Million
Q4 2024 Feb 14, 2025	SELL	$24.28 - $28.39 $735,781 - $860,330	-30,304 Reduced 14.96%	172,316 $4.4 Million
Q3 2024 Nov 14, 2024	SELL	$25.63 - $29.27 $8.26 Million - $9.43 Million	-322,194 Reduced 61.39%	202,620 $5.73 Million

Q2 2024 Aug 12, 2024	SELL	$26.26 - $29.9 $10.5 Million - $11.9 Million	-399,619 Reduced 43.23%	524,814 $13.8 Million
Q1 2024 May 15, 2024	BUY	$27.46 - $31.33 $21.4 Million - $24.4 Million	779,163 Added 536.36%	924,433 $28.1 Million
Q4 2023 Feb 12, 2024	BUY	$26.21 - $29.22 $285,505 - $318,293	10,893 Added 8.11%	145,270 $4.08 Million
Q3 2023 Nov 13, 2023	BUY	$26.26 - $31.38 $44,169 - $52,781	1,682 Added 1.27%	134,377 $3.65 Million
Q2 2023 Aug 11, 2023	BUY	$29.6 - $36.56 $3.18 Million - $3.93 Million	107,591 Added 428.58%	132,695 $4.08 Million
Q1 2023 May 15, 2023	SELL	$32.77 - $39.4 $24.6 Million - $29.6 Million	-750,073 Reduced 96.76%	25,104 $904,000
Q4 2022 Feb 14, 2023	BUY	$39.17 - $44.04 $12.1 Million - $13.6 Million	308,651 Added 66.16%	775,177 $30.6 Million
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $9.27 Million - $10.4 Million	232,534 Added 99.38%	466,526 $18.9 Million
Q2 2022 Aug 11, 2022	BUY	$37.53 - $44.22 $8.78 Million - $10.3 Million	233,992 New	233,992 $9.82 Million
Q4 2021 Feb 11, 2022	SELL	$35.17 - $42.48 $920,187 - $1.11 Million	-26,164 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$36.14 - $42.24 $333,102 - $389,326	9,217 Added 54.39%	26,164 $956,000
Q2 2021 Aug 13, 2021	BUY	$39.85 - $46.63 $675,337 - $790,238	16,947 New	16,947 $694,000
Q1 2021 May 14, 2021	SELL	$42.34 - $52.82 $776,557 - $968,771	-18,341 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$36.12 - $50.05 $444,528 - $615,965	12,307 Added 203.96%	18,341 $917,000
Q3 2020 Nov 12, 2020	BUY	$38.56 - $48.36 $232,671 - $291,804	6,034 New	6,034 $259,000

Others Institutions Holding RPRX

# of Institutions

535

Shares Held

303M

Call Options Held

1.34M

Put Options Held

252K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $17.1B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Royalty Pharma PLC Transaction History